Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells

Gene

Volumn 572, Issue 2, 2015, Pages 252-258

  Wang, Lina ^a,b   Liu, Chunyan ^a   Li, Chaoyang ^a   Xue, Jing ^a   Zhao, Shihu ^a   Zhan, Panpan ^a   Lin, Yani ^a   Zhang, Pengju ^a   Jiang, Anli ^a   Chen, Weiwen ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b JINAN INFECTIOUS DISEASE HOSPITAL   (China)

Author keywords

Apoptosis; Caspase 10; Cell proliferation; MiR 221 222; Prostate cancer

Indexed keywords

CASPASE 10; MICRORNA 221; MICRORNA 222; CASP10 PROTEIN, HUMAN; MICRORNA; MIRN221 MICRORNA, HUMAN; MIRN222 MICRORNA, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; GENETIC TRANSFECTION; MALE; MTT ASSAY; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

APOPTOSIS; CASPASE 10; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; PROSTATIC NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84941599334     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.07.017     Document Type: Article

References (34)

1. American Cancer Society Cancer Facts & Figures 2012 2012, American Cancer Society, Atlanta, GA, USA.
2. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
3. Brase J.C., Johannes M., Schlomm T., Fälth M., Haese A., Steuber T., Beissbarth T., Kuner R., Sültmann H. CirculatingmiRNAs are correlated with tumor progression in prostate cancer. Int. J. Cancer 2011, 128:608-616.
4. Bushati N., Cohen S.M. microRNA functions. Annu. Rev. Cell Dev. Biol. 2007, 23:175-205.
5. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
6. Chakravarthi B.V., Sujay R., Kuriakose G.C., Karande A.A., Jayabaskaran C. Inhibition of cancer cell proliferation and apoptosis-inducing activity of fungal taxol and its precursor baccatin III purified from endophytic Fusarium solani. Cancer Cell Int. 2013, 13:105.
7. Chen Y., Zaman M.S., Deng G., Majid S., Saini S., Liu J., Tanaka Y., Dahiya R. microRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev. Res. (Phila.) 2011, 4:76-86.
8. Ergun S., Arman K., Temiz E., Bozgeyik I., Yumrutaş Ö., Safdar M., Dağli H., Arslan A., Oztuzcu S. Expression patterns of miR-221 and its target Caspase-3 in different cancer cell lines. Mol. Biol. Rep. 2014, 41:5877-5881.
9. Galardi S., Mercatelli N., Giorda E., Massalini S., Frajese G.V., Ciafrè S.A., Farace M.G. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27kip1. J. Biol. Chem. 2007, 282:23716-23724.
10. Garofalo M., Condorelli G., Croce C.M. MicroRNAs in diseases and drug response. Curr. Opin. Pharmacol. 2008, 8:661-667.
11. Garofalo M., Condorelli G.L., Croce C.M., Condorelli G. MicroRNAs as regulators of death receptors signaling. Cell Death Differ. 2010, 17:200-208.
12. Garofalo M., Quintavalle C., Romano G., Croce C.M., Condorelli G. miR221/222 in cancer: their role in tumor progression and response to therapy. Curr. Mol. Med. 2012, 12:27-33.
13. Guo H., Ingolia N.T., Weissman J.S., Bartel D.P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466:835-840.
14. Harada K., Toyooka S., Shivapurkar N., Maitra A., Reddy J.L., Matta H., Miyajima K., Timmons C.F., Tomlinson G.E., Mastrangelo D., Hay R.J., Chaudhary P.M., Gazdar A.F. Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. Cancer Res. 2002, 62:5897-5901.
15. He H.C., Han Z.D., Dai Q.S., Ling X.H., Fu X., Lin Z.Y., Deng Y.H., Qin G.Q., Cai C., Chen J.H., Jiang F.N., Liu X., Zhong W.D. Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients. BMC Genomics 2013, 14:757.
16. Holohan C., Van Schaeybroeck S., Longley D.B., Johnston P.G. Cancer drug resistance: an evolving paradigm. Nat. Rev. Cancer 2013, 13:714-726.
17. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J. Clin. 2010, 60:277-300.
18. Lupini L., Bassi C., Ferracin M., Bartonicek N., D'Abundo L., Zagatti B., Callegari E., Musa G., Moshiri F., Gramantieri L., Corrales F.J., Enright A.J., Sabbioni S., Negrini M. miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs. Front. Genet. 2013, 4:64.
19. Park S.J., Wu C.H., Gordon J.D., Zhong X., Emami A., Safa A.R. Taxol induces caspase-10-dependent apoptosis. J. Biol. Chem. 2004, 278:51057-51067.
20. Pienta K.J., Bradley D. Mechanisms underlying the development of androgen-independent prostate cancer. Clin. Cancer Res. 2006, 12:1665-1671.
21. Rana T.M. Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell Biol. 2007, 8:23-36.
22. Schaefer A., Jung M., Mollenkopf H.J., Wagner I., Stephan C., Jentzmik F., Miller K., Lein M., Kristiansen G., Jung K. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int. J. Cancer 2010, 126:1166-1176.
23. Shen J., Hruby G.W., McKiernan J.M., Gurvich I., Lipsky M.J., Benson M.C., Santella R.M. Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer. Prostate 2012, 72:1469-1477.
24. Shin M.S., Kim H.S., Lee S.H., Lee J.W., Song Y.H., Kim Y.S., Park W.S., Kim S.Y., Lee S.N., Park J.Y., Lee J.H., Xiao W., Jo K.H., Wang Y.P., Lee K.Y., Park Y.G., Kim S.H., Lee J.Y., Yoo N.J. Alterations of Fas-pathway genes associated with nodal metastasis in non-small cell lung cancer. Oncogene 2002, 21:4129-4136.
25. Shin M.S., Kim H.S., Kang C.S., Park W.S., Kim S.Y., Lee S.N., Lee J.H., Park J.Y., Jang J.J., Kim C.W., Kim S.H., Lee J.Y., Yoo N.J., Lee S.H. Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood 2002, 99:4094-4099.
26. Song H., Liu Y., Pan J., Zhao S.T. Expression profile analysis reveals putative prostate cancer-related microRNAs. Genet. Mol. Res. 2013, 12:4934-4943.
27. Sun T., Wang Q., Balk S., Brown M., Lee G.S., Kantoff P. The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines. Cancer Res. 2009, 69:3356-3363.
28. Sun T., Wang X., He H.H., Sweeney C.J., Liu S.X., Brown M., Balk S., Lee G.S., Kantoff P.W. miR-221 promotes the development of androgen independence in prostate cancer cells via down regulation of HECTD2 and RAB1A. Oncogene 2014, 33:2790-2800.
29. Terasawa K., Ichimura A., Sato F., Shimizu K., Tsujimoto G. Sustained activation of ERK1/2 by NGF induces microRNA-221 and 222 in PC12 cells. FEBS J. 2009, 276:3269-3276.
30. Wach S., Nolte E., Szczyrba J., Stöhr R., Hartmann A., Ørntoft T., Dyrskjøt L., Eltze E., Wieland W., Keck B., Ekici A.B., Grässer F., Wullich B. MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening. Int. J. Cancer 2012, 130:611-621.
31. Wang J., Chun H.J., Wong W., Spencer D.M., Lenardo M.J. Caspase-10 is an initiator caspase in deathreceptor signaling. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:13884-13888.
32. Wang L., Du F., Wang X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 2008, 133:693-703.
33. Yang J., Zhang J.Y., Chen J., Xu Y., Song N.H., Yin C.J. Prognostic role of microRNA-221 in various human malignant neoplasms: a meta-analysis of 20 related studies. PLoS One 2014, 9:87606.
34. Zhang W., Zang J., Jing X., Sun Z., Yan W., Yang D., Shen B., Guo F. Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer. J. Transl. Med. 2014, 12:66.